Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
---|---|---|---|---|---|
Gross Sales | 72.59 | 65.09 | 59.51 | 66.75 | 60.73 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 72.59 | 65.09 | 59.51 | 66.75 | 60.73 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.91 | 0.82 | 0.6 | 1.31 | 1.12 |
Total Income | 73.49 | 65.91 | 60.11 | 68.07 | 61.85 |
Total Expenditure | 48.84 | 45.91 | 41.26 | 43.56 | 40.13 |
PBIDT | 24.66 | 20 | 18.86 | 24.51 | 21.72 |
Interest | 2.7 | 2.06 | 1.98 | 2.13 | 2.22 |
PBDT | 21.95 | 17.94 | 16.87 | 22.38 | 19.51 |
Depreciation | 9.48 | 8.73 | 8.83 | 8.75 | 8.99 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 2.88 | 1.47 | 2.15 | 3.58 | 3.09 |
Deferred Tax | 0.42 | 0.57 | -0.09 | -0.1 | -0.25 |
Reported Profit After Tax | 9.18 | 7.17 | 5.98 | 10.16 | 7.67 |
Minority Interest After NP | -0.22 | -0.22 | -0.17 | -0.19 | -0.27 |
Net Profit after Minority Interest | 9.4 | 7.39 | 6.15 | 10.34 | 7.94 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 9.4 | 7.39 | 6.15 | 10.34 | 7.94 |
EPS (Unit Curr.) | 1.8 | 1.42 | 1.18 | 1.94 | 1.49 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 10.41 | 10.41 | 10.42 | 8.63 | 8.63 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 33.97 | 30.72 | 31.69 | 36.71 | 35.76 |
PBDTM(%) | 30.23 | 27.56 | 28.34 | 33.52 | 32.12 |
PATM(%) | 12.64 | 11.01 | 10.04 | 15.22 | 12.62 |
Suraksha Diagnostics specializes in medical consultancy services, hoping to attract investors in the rising healthcare sector
The anchor book, available to institutional investors, will open a day earlier, on November 28, 2024.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.